Bleeding patterns of women with heavy menstrual bleeding or dysmenorrhoea using the levonorgestrel-releasing intrauterine system: results from a real-world observational study in Japan (J-MIRAI)

References

• Davies J, Kadir RA. Heavy menstrual bleeding: an update on management. Thromb Res. 2017;151(Suppl 1):S70–S77.
   PubMedGoogle Scholar
• Japan Society of Obstetrics and Gynecology. Obstetrics and gynecology glossary. 4th ed. Tokyo: Kyorinsya; 2018.
   Google Scholar
• Naoulou B, Tsai MC. Efficacy of tranexamic acid in the treatment of idiopathic and non-functional heavy menstrual bleeding: a systematic review. Acta Obstet Gynecol Scand. 2012;91(5):529–537.
   PubMed Web of Science ®Google Scholar
• Fraser IS, Mansour D, Breymann C, et al. Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. Int J Gynaecol Obstet. 2015;128(3):196–200.
   PubMed Web of Science ®Google Scholar
• Wang W, Bourgeois T, Klima J, et al. Iron deficiency and fatigue in adolescent females with heavy menstrual bleeding. Haemophilia. 2013;19(2):225–230.
   PubMed Web of Science ®Google Scholar
• Kawaguchi R, Matsumoto K, Ishikawa T, et al. Guideline for gynecological practice in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2020 edition. J Obstet Gynaecol Res. 2021;47(1):5–25.
   PubMed Web of Science ®Google Scholar
• Munro MG, Critchley HOD, Fraser IS, FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143(3):393–408.
   PubMed Web of Science ®Google Scholar
• Tanaka E, Momoeda M, Osuga Y, et al. Burden of menstrual symptoms in Japanese women: results from a survey-based study. J Med Econ. 2013;16(11):1255–1266.
   PubMedGoogle Scholar
• Karlsson TS, Marions LB, Edlund MG. Heavy menstrual bleeding significantly affects quality of life. Acta Obstet Gynecol Scand. 2014;93(1):52–57.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management NICE guideline [NG88]. 2018 [accessed 14 Dec 2020]. https://www.nice.org.uk/guidance/ng88
   Google Scholar
• United States Food and Drug Administration. Mirena® (levonorgestrel-releasing intrauterine system) product label. 2008 [accessed 14 Dec 2020]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021225s031lbl.pdf
   Google Scholar
• Silverberg SG, Haukkamaa M, Arko H, et al. Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices. Int J Gynecol Pathol. 1986;5:235–241.
   Google Scholar
• Lethaby A, Hussain M, Rishworth JR, et al. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2015. Cd002126.
   Google Scholar
• Pharmaceuticals and Medical Devices Agency. Mirena intrauterine delivery system 52 mg. Japanese Package insert. 2019 [accessed 14 Dec 2020]. https://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/630004_2529710X1027_1_07
   Google Scholar
• Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990;97(8):734–739.
   PubMedGoogle Scholar
• Belsey EM, Machin D, d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction. Contraception. 1986;34(3):253–260.
   PubMedGoogle Scholar
• Momoeda M, Tanaka E, Kawaguchi M. Development of the Japanese version of the Menorrhagia Multi-Attribute Scale (MMAS): translation and linguistic validation. Obstetr Gynecol. 2015;82:1299–1305.
   Google Scholar
• Magnay JL, O'Brien S, Gerlinger C, et al. Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review. BMC Womens Health. 2020;20(1):24.
   PubMed Web of Science ®Google Scholar
• Reid PC, Virtanen-Kari S. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. BJOG. 2005;112(8):1121–1125.
   PubMed Web of Science ®Google Scholar
• Jensen J, Mansour D, Lukkari-Lax E, et al. Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies. Contraception. 2013;87(1):107–112.
   PubMed Web of Science ®Google Scholar
• Maldonado LY, Sergison JE, Gao X, et al. Menstrual bleeding and spotting with the levonorgestrel intrauterine system (52 mg) during the first-year after insertion: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;222(5):451–468.e9.
   PubMed Web of Science ®Google Scholar
• Chen BA, Eisenberg DL, Schreiber CA, et al. Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding. Am J Obstet Gynecol. 2020;222(4S):S888.e1–e6.
   Google Scholar
• Schreiber CA, Teal SB, Blumenthal PD, et al. Bleeding patterns for the Liletta® levonorgestrel 52 mg intrauterine system. Eur J Contracept Reprod Health Care. 2018;23(2):116–120.
   PubMed Web of Science ®Google Scholar
• Gupta J, Kai J, Middleton L, et al. Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med. 2013;368(2):128–137.
   PubMed Web of Science ®Google Scholar
• Xu L, Lee BS, Asif S, et al. Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy. Int J Womens Health. 2014;6:547–554.
   PubMedGoogle Scholar